Rapport Therapeutics (RAPP) stated RAP-219 / bipolar mania Phase 2 · Topline results: “in the first half of 2027” (SEC 8-K, Exhibit 99.1, filed ); the most recent dated timing wording located () was “in October 2026” (SEC Form 10-Q · and SEC 8-K, Exhibit 99.1 · ).
Equivalent half-year, quarter, and year notations are compared together while original wording stays visible. Qualifiers such as early, mid, late, and end remain distinct. A slash and or are compared together for two complete timing alternatives with explicit years. Each source is compared with the preceding checked date. Different wording in documents from the same day is shown separately, without assigning an order within that day. No comparison is made against a preceding date with different timing expressions. Status is set by founder review of the original filings.
Document
Date
Event retained
Exact company wording
Review
Source
SEC 8-K, Exhibit 99.1
Initial entry within checked sources: “in the first half of 2027”
topline results expected in the first half of 2027
Enrollment in the Phase 2 trial is progressing well and topline results are now expected in the fourth quarter of 2026, ahead of the previous guidance of first half of 2027. Exhibit 99.1: Bipolar Mania Phase 2 Trial Topline Results section; sentence beginning Enrollment in the Phase 2 trial
Last checked: . Compared by hand with the original filings by Jiwoo Seong (Woo).
Corrections
No corrections yet (as of ).
A correction is added here with its date, what changed, why, and the evidence. The earlier version is not deleted. Report an error: hello@orionbiotechai.com. If you want your name shown with the correction, include it; otherwise no name is shown.
Rapport Therapeutics (RAPP) — RAP-219 / bipolar mania Phase 2 · Topline results: “in the first half of 2027” (SEC 8-K, Exhibit 99.1 2025-03-11); wording changed from “in the first half of 2027” (2025-03-11) to “in the fourth quarter of 2026” (2026-05-07); wording changed from “in the fourth quarter of 2026” (2026-05-07) to “in October 2026” (2026-08-05); wording changed from “in the fourth quarter of 2026” (2026-05-07) to “in October 2026” (2026-08-05). Status Timing changed, checked 2026-10-12. Sources: https://www.sec.gov/Archives/edgar/data/2012593/000095017025036822/rapp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2012593/000119312526210324/rapp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2012593/000119312526333853/rapp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2012593/000119312526333862/rapp-20260630.htm
Terms
First stated window
The timing wording in the earliest company statement located within the sources checked, quoted as written (for example “2H 2026”). An earlier statement may exist outside those sources.
Disclosure date
The date of the filing or company release that disclosed the readout. “None found” means no such disclosure was located in the sources checked. SEC filings were searched through the “SEC filings searched through” date shown.
1H, 2H, 1Q–4Q
First or second half, or first to fourth quarter, of the year named, as the company wrote it. Equivalent notations are compared together; the original wording stays visible.
SEC original
The filing as published on the SEC EDGAR system. “Company original” is the release on the company's own investor site.
Status
One of seven labels set by founder review of the original filings. Definitions: Methodology. Status definitions.
